Although the study by Hawkins et al1 provides valuable new information regarding the epidemiologic features of persistent Staphylococcus aureus bacteremia (pSAB), it leaves certain important questions unanswered and is potentially misleading regarding others. First, the authors state that vancomycin drug levels were “not determined ” in their study, precluding comment on the relationship between vancomycin levels and outcomes, which, as noted by the authors,1 is an important and currently controversial topic. It is hard to imagine that vancomycin levels truly were not obtained for their subjects as a part of routine clinical care. Presumably, in their study, “not determined ” means “not extracted during the medical record review.” This would seem to be a significant omission but one that could be readily remedied by a focused search of laboratory records. Such an analysis might provide insights into whether more aggressive vancomycin dosing can prevent pSAB or the associated adverse clinical outcomes. Second, regarding clinical outcomes, the abstract emphasizes that these were significantly worse among patients with pSAB, yet the multivariable analysis found no independent association of pSAB with crude mortality (the only outcome for which multivariable analysis was reported). It would be important to know whether the other outcomes (hospital duration, sepsis, and attributable mortality) retained their significant associations with pSAB in multivariable analysis. If so, these results should be presented. If not, the emphasis on adverse outcomes would seem unwarranted, at least from the perspective of the currently implied causal relationship.
Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more
Subscribe for full-text access to content from 1998 forward and a host of useful features
Activate your current subscription (AMA members and current subscribers)
Purchase Online Access to this article for 24 hours
Thank you for submitting a comment on this article. It will be reviewed by JAMA Internal Medicine editors. You will be notified when your comment has been published. Comments should not exceed 500 words of text and 10 references.
Do not submit personal medical questions or information that could identify a specific patient, questions about a particular case, or general inquiries to an author. Only content that has not been published, posted, or submitted elsewhere should be submitted. By submitting this Comment, you and any coauthors transfer copyright to the journal if your Comment is posted.
* = Required Field
Disclosure of Any Conflicts of Interest*
Indicate all relevant conflicts of interest of each author below, including all relevant financial interests, activities, and relationships within the past 3 years including, but not limited to, employment, affiliation, grants or funding, consultancies, honoraria or payment, speakers’ bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued. If all authors have none, check "No potential conflicts or relevant financial interests" in the box below. Please also indicate any funding received in support of this work. The information will be posted with your response.
Some tools below are only available to our subscribers or users with an online account.
Download citation file:
Web of Science® Times Cited: 1
Customize your page view by dragging & repositioning the boxes below.
More Listings atJAMACareerCenter.com >
and access these and other features:
Enter your username and email address. We'll send you a link to reset your password.
Enter your username and email address. We'll send instructions on how to reset your password to the email address we have on record.
Athens and Shibboleth are access management services that provide single sign-on to protected resources. They replace the multiple user names and passwords necessary to access subscription-based content with a single user name and password that can be entered once per session. It operates independently of a user's location or IP address. If your institution uses Athens or Shibboleth authentication, please contact your site administrator to receive your user name and password.